Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Samsung Biologics Co.,Ltd.

Capitalization 76,102B 51.24B 44.18B 39.88B 38.27B 69.78B 4,709B 73.03B 471B 189B 2,258B 192B 188B 8,077B P/E ratio 2026 *
44.8x
P/E ratio 2027 * 35.5x
Enterprise value 72.95B 49.12M 42.35M 38.23M 36.68M 66.89M 4.51B 70M 452M 181M 2.16B 184M 180M 7.74B EV / Sales 2026 *
13.5x
EV / Sales 2027 * 10.3x
Free-Float
25.44%
Yield 2026 *
-
Yield 2027 * 0.03%
1 day-3.95%
1 week+57.90%
Current month+57.90%
1 month+57.90%
3 months+57.90%
6 months+57.90%
Current year+57.90%
1 week 1,000,000
Extreme 999999.9999
1,668,000
1 month 1,000,000
Extreme 999999.9999
1,668,000
Current year 1,000,000
Extreme 999999.9999
1,668,000
1 year 1,000,000
Extreme 999999.9999
1,668,000
3 years 1,000,000
Extreme 999999.9999
1,668,000
5 years 1,000,000
Extreme 999999.9999
1,668,000
10 years 192,960.76
Extreme 192960.7607
1,668,000
Manager TitleAgeSince
Chief Executive Officer 64 09/12/2020
Director of Finance/CFO 58 14/03/2025
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Chairman 64 09/12/2020
Director/Board Member 72 29/03/2022
Director/Board Member 67 20/03/2020
Change 5d. change 1-year change 3-years change Capi.($)
-0.18%+57.90%+57.90%+57.90% 51.24B
+1.18%-3.62%+2.33%+2.48% 77.98B
+1.00%+1.64%+49.76%+213.91% 55.42B
-2.77%-3.09%-45.23%-52.13% 49.37B
-0.16%-2.48%+21.68%-29.19% 27.13B
+0.27%-0.24%+46.61%-61.62% 20.74B
-0.47%-5.34%+33.14%+29.98% 19.09B
-1.86%-3.94%+103.36%+104.89% 18.48B
-0.56%-4.07%+25.45%+54.03% 14.15B
-1.74%-10.06%-0.54%+915.24% 13.43B
Average -0.88%-3.38%+29.45%+123.55% 34.7B
Weighted average by Cap. -0.75%-3.20%+23.41%+74.75%

Financials

2026 *2027 *
Net sales 5,396B 3.63B 3.13B 2.83B 2.71B 4.95B 334B 5.18B 33.43B 13.39B 160B 13.64B 13.35B 573B 6,992B 4.71B 4.06B 3.66B 3.52B 6.41B 433B 6.71B 43.32B 17.36B 208B 17.67B 17.29B 742B
Net income 1,815B 1.22B 1.05B 951M 913M 1.66B 112B 1.74B 11.25B 4.51B 53.87B 4.59B 4.49B 193B 2,244B 1.51B 1.3B 1.18B 1.13B 2.06B 139B 2.15B 13.9B 5.57B 66.6B 5.67B 5.55B 238B
Net Debt -3,156B -2.12B -1.83B -1.65B -1.59B -2.89B -195B -3.03B -19.55B -7.83B -93.64B -7.97B -7.8B -335B -3,885B -2.62B -2.26B -2.04B -1.95B -3.56B -240B -3.73B -24.07B -9.64B -115B -9.82B -9.61B -412B
Logo Samsung Biologics Co.,Ltd.
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.
Employees
4,770
Date Price Change Volume
09/03/26 1,579,000.00 -3.95% 56,445
06/03/26 1,644,000.00 -0.18% 57,347
05/03/26 1,647,000.00 +8.64% 70,178
04/03/26 1,516,000.00 -9.82% 83,414
03/03/26 1,681,000.00 -5.46% 81,261
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
1,644,000.00KRW
Average target price
2,253,934.38KRW
Spread / Average Target
+37.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A207940 Stock
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW